Diabetes Technologies - What the General Physician Needs to Know

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2020 Sep 16

PMID 32934039

Citations 4

Authors

Adrian Li

Sufyan Hussain

Affiliations

Soon will be listed here.

Abstract

Technology has revolutionised our society. From the creation of the internet to smartphones and applications (apps), technology has changed how we communicate with each other, undertake regular tasks in our lives and access information at our fingertips. Technology has also transformed how we deliver healthcare with electronic patient records, more sensitive imaging modalities and newer treatments that are less invasive yet more cost-effective. The management of diabetes mellitus is an area that has kept pace with this revolution. With the emergence of a range of widely used technological options that can improve quality of life and metabolic outcomes, general physicians need to be aware of their application in diabetes, as well as how to manage acute diabetes presentations in people using these devices. This article aims to improve the knowledge that general physicians may have with diabetes technologies and guide them on the acute management in people using these technologies.

Citing Articles

Accuracy of Continuous Glucose Monitoring in Hemodialysis Patients With Diabetes.

Narasaki Y, Kalantar-Zadeh K, Daza A, You A, Novoa A, Peralta R Diabetes Care. 2024; 47(11):1922-1929.

PMID: 39213372 PMC: 11502529. DOI: 10.2337/dc24-0635.

The barriers and facilitators to managing diabetes with insulin in adults with intellectual disabilities: A systemised review of the literature.

Beresford C, Kozlowska O J Appl Res Intellect Disabil. 2022; 35(6):1253-1266.

PMID: 35983585 PMC: 9805117. DOI: 10.1111/jar.13027.

Technology in the management of type 2 diabetes: Present status and future prospects.

Daly A, Hovorka R Diabetes Obes Metab. 2021; 23(8):1722-1732.

PMID: 33950566 PMC: 7611289. DOI: 10.1111/dom.14418.

Transformation: fighting the past or building the new?.

Emmanuel A Clin Med (Lond). 2020; 20(5):445.

PMID: 32934034 PMC: 7539719. DOI: 10.7861/clinmed.ed.20.5.1.

References

Ghazanfar H, Rizvi S, Khurram A, Orooj F, Qaiser I . Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab. 2016; 20(4):506-11. PMC: 4911840. DOI: 10.4103/2230-8210.183472. View

Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E . Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2015; 32(1):21-39. PMC: 5033023. DOI: 10.1002/dmrr.2653. View

Pickup J, Ford Holloway M, Samsi K . Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care. 2015; 38(4):544-50. DOI: 10.2337/dc14-1855. View

Choudhary P, Campbell F, Joule N, Kar P . A Type 1 diabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes. Diabet Med. 2019; 36(5):531-538. DOI: 10.1111/dme.13933. View

Clarke S, Foster J . A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012; 69(2):83-93. View

Perera R, Oliver N, Wilmot E, Marriott C . Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England. Diabet Med. 2018; 35(11):1617-1618. DOI: 10.1111/dme.13766. View

Marshall D, Holloway M, Korer M, Woodman J, Brackenridge A, Hussain S . Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians. Diabetes Ther. 2019; 10(5):1553-1564. PMC: 6778569. DOI: 10.1007/s13300-019-00679-y. View

Jennings P, Hussain S . Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. J Diabetes Sci Technol. 2019; 14(5):868-877. PMC: 7753866. DOI: 10.1177/1932296819894296. View

Harding S, Britten N, Bristow D . The performance of junior doctors in applying clinical pharmacology knowledge and prescribing skills to standardized clinical cases. Br J Clin Pharmacol. 2010; 69(6):598-606. PMC: 2883752. DOI: 10.1111/j.1365-2125.2010.03645.x. View

10.

Kelly N, Brandom K, Mattick K . Improving preparedness of medical students and junior doctors to manage patients with diabetes. BMJ Open Diabetes Res Care. 2015; 3(1):e000116. PMC: 4586938. DOI: 10.1136/bmjdrc-2015-000116. View

11.

Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska M . Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. N Engl J Med. 2018; 379(6):547-556. DOI: 10.1056/NEJMoa1805233. View

12.

Boughton C, Hovorka R . Closed-loop management of inpatient hyperglycaemia. Br J Hosp Med (Lond). 2019; 80(11):665-669. DOI: 10.12968/hmed.2019.80.11.665. View

13.

Prahalad P, Tanenbaum M, Hood K, Maahs D . Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabet Med. 2018; 35(4):419-429. DOI: 10.1111/dme.13588. View

14.

DeVries J, Snoek F, Kostense P, Masurel N, Heine R . A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002; 25(11):2074-80. DOI: 10.2337/diacare.25.11.2074. View

15.

Tauschmann M, Thabit H, Bally L, Allen J, Hartnell S, Wilinska M . Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018; 392(10155):1321-1329. PMC: 6182127. DOI: 10.1016/S0140-6736(18)31947-0. View

16.

Khunti K, Nikolajsen A, Thorsted B, Andersen M, Davies M, Paul S . Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. 2016; 18(4):401-9. PMC: 5067688. DOI: 10.1111/dom.12626. View

17.

Kropff J, Choudhary P, Neupane S, Barnard K, Bain S, Kapitza C . Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. Diabetes Care. 2016; 40(1):63-68. DOI: 10.2337/dc16-1525. View

18.

Ancona P, Eastwood G, Lucchetta L, Ekinci E, Bellomo R, Martensson J . The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc. 2017; 19(2):167-174. View

19.

Tyndall V, Stimson R, Zammitt N, Ritchie S, McKnight J, Dover A . Marked improvement in HbA following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia. 2019; 62(8):1349-1356. PMC: 6647076. DOI: 10.1007/s00125-019-4894-1. View

20.

Beck R, Bergenstal R, Laffel L, Pickup J . Advances in technology for management of type 1 diabetes. Lancet. 2019; 394(10205):1265-1273. DOI: 10.1016/S0140-6736(19)31142-0. View